FITM1 and cancer: Based on the investigation of 101 non-viral HCC patients in TCGA, we demonstrate that the hypermethylated FITM1 down-regulates the corresponding FITM1 expression, thereby promoting the progression of non-viral HCC via cancer-related pathways.